Baird Maintains Outperform on Boston Scientific, Raises Price Target to $63
Portfolio Pulse from Benzinga Newsdesk
Baird analyst David Rescott maintains an Outperform rating on Boston Scientific (NYSE:BSX) and raises the price target from $60 to $63.
September 21, 2023 | 4:39 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Boston Scientific's price target has been raised from $60 to $63 by Baird, which maintains an Outperform rating on the stock.
The raised price target indicates that the analyst sees further upside potential in the stock, which could lead to positive sentiment among investors and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100